News
CBD mocktails are emerging as a science-forward alternative to alcohol, offering the ritual of social drinking without intoxication. Recent peer-reviewed research suggests cannabidiol, or CBD, may influence alcohol craving, stress response, cue-triggered reward pathways, and the endocannabinoid system. While CBD is not a cure or treatment for alcohol use disorder, studies show promising early findings around CBD’s role in reducing alcohol cravings and supporting a calmer, non-intoxicating beverage experience. As more people seek alcohol-free drinks, functional mocktails, and healthier ways to unwind, CBD-infused mocktails represent the next evolution of social drinking.
CBD may have started the conversation, but CBG is quickly becoming the cannabinoid researchers can’t stop studying. From groundbreaking human trials on anxiety to emerging research on gut health, metabolism, and neuroprotection, discover why scientists are calling CBG the next frontier in cannabinoid wellness.
What if one of the most promising compounds for colorectal cancer… isn’t a drug—but a cannabinoid most people have never even heard of?
CBG (the “mother cannabinoid”) is quietly showing powerful anti-tumor effects in early research—slowing cancer growth, triggering cell death, and targeting pathways specific to colon cancer. But here’s the catch: it doesn’t work in isolation.
The real shift happens when you combine targeted cannabinoids, gut-healing nutrition, and anti-inflammatory lifestyle changes into one strategic protocol. Because when it comes to colorectal cancer, healing isn’t about one miracle solution—it’s about changing the entire environment cancer depends on.
Lipedema is not a weight problem, it’s a biological one.
Driven by inflammation, lymphatic dysfunction, and connective tissue changes, this condition requires a completely different approach than traditional fat loss. Here’s what research actually shows - and what to do instead.
Emerging peer-reviewed research suggests that non-psychoactive cannabidiol (CBD) may do more than reduce inflammation—it may influence molecular pathways involved in intestinal fibrosis and gut health. Recent studies highlight CBD’s interaction with key signaling systems such as Nrf2 and TGF-β/SMAD, offering new insight into how cannabinoids may support gut resilience without intoxication. This science-forward review breaks down what the latest research actually shows.
